KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Receivables (2016 - 2025)

Historic Receivables for CareDx (CDNA) over the last 13 years, with Q3 2025 value amounting to $47.8 million.

  • CareDx's Receivables fell 2819.13% to $47.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $47.8 million, marking a year-over-year decrease of 2819.13%. This contributed to the annual value of $64.6 million for FY2024, which is 2652.51% up from last year.
  • Latest data reveals that CareDx reported Receivables of $47.8 million as of Q3 2025, which was down 2819.13% from $67.4 million recorded in Q2 2025.
  • CareDx's Receivables' 5-year high stood at $30.0 billion during Q1 2021, with a 5-year trough of $47.8 million in Q3 2025.
  • In the last 5 years, CareDx's Receivables had a median value of $66.2 million in 2024 and averaged $4.8 billion.
  • In the last 5 years, CareDx's Receivables soared by 13124276.08% in 2021 and then tumbled by 9978.23% in 2022.
  • Quarter analysis of 5 years shows CareDx's Receivables stood at $59.8 million in 2021, then increased by 10.96% to $66.3 million in 2022, then dropped by 23.0% to $51.1 million in 2023, then increased by 26.53% to $64.6 million in 2024, then fell by 25.94% to $47.8 million in 2025.
  • Its Receivables stands at $47.8 million for Q3 2025, versus $67.4 million for Q2 2025 and $71.5 million for Q1 2025.